La maladie de Parkinson en France (serveur d'exploration) - Exploration (Accueil)

Index « Keywords » - entrée « Oxidopamine »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Oxidative stress < Oxidopamine < Oxidopamine (administration & dosage)  Facettes :

List of bibliographic references indexed by Oxidopamine

Number of relevant bibliographic references: 63.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000168 (2016) Manale Bensaid [France] ; Patrick P. Michel [France] ; Stewart D. Clark [États-Unis] ; Etienne C. Hirsch [France] ; Chantal François [France]Role of pedunculopontine cholinergic neurons in the vulnerability of nigral dopaminergic neurons in Parkinson's disease.
000477 (2015) Emilie Faggiani [France] ; Claire Delaville [France] ; Abdelhamid Benazzouz [France]The combined depletion of monoamines alters the effectiveness of subthalamic deep brain stimulation.
000585 (2015) Xavier Lévêque [France] ; Elodie Mathieux ; Véronique Nerrière-Daguin ; Reynald Thinard ; Laetitia Kermarrec ; Tony Durand ; Thomas Haudebourg ; Bernard Vanhove ; Laurent Lescaudron ; Isabelle Neveu ; Philippe NaveilhanLocal control of the host immune response performed with mesenchymal stem cells: perspectives for functional intracerebral xenotransplantation.
000704 (2015) Nicolas Maurice [France] ; Thierry Deltheil [France] ; Christophe Melon [France] ; Bertrand Degos [France] ; Christiane Mourre [France] ; Marianne Amalric [France] ; Lydia Kerkerian-Le Goff [France]Bee Venom Alleviates Motor Deficits and Modulates the Transfer of Cortical Information through the Basal Ganglia in Rat Models of Parkinson’s Disease
000862 (2014) Wai Kin D. Ko [France] ; Marie-Laure Martin-Negrier [France] ; Erwan Bezard [France] ; Alan R. Crossman [Royaume-Uni] ; Paula Ravenscroft [Royaume-Uni]RGS4 is involved in the generation of abnormal involuntary movements in the unilateral 6-OHDA-lesioned rat model of Parkinson's disease.
000904 (2014) Anissa El Arfani [Belgique] ; Eduard Bentea [Belgique] ; Najat Aourz [Belgique] ; Ben Ampe [Belgique] ; Philippe De Deurwaerdère [France] ; Ann Van Eeckhaut [Belgique] ; Ann Massie [Belgique] ; Sophie Sarre [Belgique] ; Ilse Smolders [Belgique] ; Yvette Michotte [Belgique]NMDA receptor antagonism potentiates the L-DOPA-induced extracellular dopamine release in the subthalamic nucleus of hemi-parkinson rats.
000920 (2014) Cristina Alcacer [France] ; Fanny Charbonnier-Beaupel [France] ; Jean-Christophe Corvol [France] ; Jean-Antoine Girault [France] ; Denis Hervé [France]Mitogen- and stress-activated protein kinase 1 is required for specific signaling responses in dopamine-denervated mouse striatum, but is not necessary for L-DOPA-induced dyskinesia.
000935 (2014) Wisam Dieb [France] ; Omar Ouachikh [France] ; Franck Durif [France] ; Aziz Hafidi [France]Lesion of the dopaminergic nigrostriatal pathway induces trigeminal dynamic mechanical allodynia
000B31 (2014) Omar Ouachikh [France] ; Wisam Dieb [France] ; Franck Durif [France] ; Aziz Hafidi [France]Anterior ventral tegmental area dopaminergic neurons are not involved in the motivational effects of bromocriptine, pramipexole and cocaine in drug-free rats
000C23 (2013) Khaled-Ezaheir Bennouar [France] ; Michelle A. Uberti ; Christophe Melon ; Maria D. Bacolod ; Hermogenes N. Jimenez ; Manuel Cajina ; Lydia Kerkerian-Le Goff ; Darío Doller ; Paolo GubelliniSynergy between L-DOPA and a novel positive allosteric modulator of metabotropic glutamate receptor 4: implications for Parkinson's disease treatment and dyskinesia.
000C42 (2013) Michel Engeln [France] ; Serge H. Ahmed [France] ; Caroline Vouillac [France] ; François Tison [France] ; Erwan Bezard [France] ; Pierre-Olivier Fernagut [France]Reinforcing properties of Pramipexole in normal and parkinsonian rats.
000F46 (2013) M. Lagière [France] ; S. Navailles [France] ; L. Mignon [États-Unis] ; A. Roumegous [France] ; M.-F. Chesselet [États-Unis] ; P. De Deurwaerdère [France]The enhanced oral response to the 5-HT2 agonist Ro 60-0175 in parkinsonian rats involves the entopeduncular nucleus: electrophysiological correlates
000F67 (2013) P. M. Abedi [France, Maroc] ; C. Delaville [France] ; P. De Deurwaerdere [France] ; W. Benjelloun [Maroc] ; A. Benazzouz [France]INTRAPALLIDAL ADMINISTRATION OF 6-HYDROXYDOPAMINE MIMICS IN LARGE PART THE ELECTROPHYSIOLOGICAL AND BEHAVIORAL CONSEQUENCES OF MAJOR DOPAMINE DEPLETION IN THE RAT
000F77 (2013) M. Rolland [France] ; C. Carcenac [France] ; P. G. Overton [Royaume-Uni] ; M. Savasta [France] ; V. Coizet [France]ENHANCED VISUAL RESPONSES IN THE SUPERIOR COLLICULUS AND SUBTHALAMIC NUCLEUS IN AN ANIMAL MODEL OF PARKINSON'S DISEASE
000F79 (2013) Omar Ouachikh [France] ; Wisam Dieb [France] ; Franck Durif [France] ; Aziz Hafidi [France]Differential behavioral reinforcement effects of dopamine receptor agonists in the rat with bilateral lesion of the posterior ventral tegmental area
001146 (2012) Antoine Fouillet [France] ; Clemence Levet [France] ; Angelique Virgone [France] ; Marion Robin [France] ; Pierre Dourlen [France] ; Jennifer Rieusset [France] ; Elise Belaidi [France] ; Michel Ovize [France] ; Monique Touret [France] ; Serge Nataf [France] ; Bertrand Mollereau [France]ER stress inhibits neuronal death by promoting autophagy
001404 (2012) J. Bove [Espagne] ; C. Perier [Espagne]NEUROTOXIN-BASED MODELS OF PARKINSON'S DISEASE
001438 (2012) H. Iderberg [Suède] ; V. Francardo [Suède] ; E. Y. Pioll [Royaume-Uni]ANIMAL MODELS OF L-DOPA-INDUCED DYSKINESIA: AN UPDATE ON THE CURRENT OPTIONS
001858 (2011) Brigitte Spinnewyn [France] ; Christelle Charnet [France] ; Sylvie Cornet [France] ; Veronique Roubert [France] ; Pierre-Etienne Chabrier [France] ; Michel Auguet [France]An improved model to investigate the efficacy of antidyskinetic agents in hemiparkinsonian rats
001A12 (2010) B. Greco [France] ; S. Lopez ; H. Van Der Putten ; P J Flor ; M. AmalricMetabotropic glutamate 7 receptor subtype modulates motor symptoms in rodent models of Parkinson's disease.
001A27 (2010) Sylvia Navailles [France] ; Abdelhamid Benazzouz ; Bernard Bioulac ; Christian Gross ; Philippe De DeurwaerdèreHigh-frequency stimulation of the subthalamic nucleus and L-3,4-dihydroxyphenylalanine inhibit in vivo serotonin release in the prefrontal cortex and hippocampus in a rat model of Parkinson's disease.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Oxidopamine" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Oxidopamine" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Oxidopamine
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024